Problem

Cresta addresses the cost, inconsistency, and limited scalability of enterprise customer-experience operations, particularly large contact centers. Its target customers are typically Fortune 1000 organizations with at least 100 care agents or 50 sales agents, where small improvements in automation, handling time, revenue conversion, and customer satisfaction can have substantial financial impact. Cresta frames the measurable economics around containment, revenue, average handle time, and CSAT.

The main use case is improving customer interactions at scale: AI can handle or contain routine conversations, while human agents receive real-time assistance when cases require judgment or intervention. This tackles the connected problems of contact-volume automation and human-agent performance rather than treating them as separate initiatives.

Product / Service

Cresta is an enterprise generative-AI platform for customer experience that unifies human and AI agents on a single system. Its offering combines AI agents with real-time agent guidance and conversation intelligence, enabling organizations to automate interactions, support live agents during conversations, and use interaction data to improve quality and performance.

The benefit is a more coordinated customer-experience operation: enterprises can pursue automation while also making human agents more effective, with outcomes measured in containment, revenue, average handle time, and CSAT. The available evidence describes the product as an enterprise platform rather than a standalone point solution, although it does not specify the exact commercial or technical delivery model.

Market

Cresta competes in enterprise contact-center AI and generative AI for customer experience, spanning AI agents, agent assist, conversation intelligence, real-time coaching, and automated quality management. Its positioning is differentiated from narrower tools by connecting customer-facing automation with human-agent guidance and performance analytics. Competitors and alternatives identified in the evidence include Balto and Decagon, with Balto specifically positioned as a real-time alternative.

Cresta is not presented as pre-revenue or merely experimental: the company says it delivers production-grade outcomes at Fortune 500 scale, and it serves large enterprise operations across sectors including telecommunications, financial services, insurance, healthcare, travel and hospitality, retail, home services, and automotive. Its traction also includes a $125 million Series D announced in November 2024, bringing total funding to more than $270 million; the evidence does not provide revenue figures.